Steven Stein
Chief Tech/Sci/R&D Officer presso INCYTE CORPORATION
Patrimonio netto: 6 M $ in data 31/03/2024
Profilo
Steven H. Stein ricopre la posizione di Chief Medical Officer & Executive Vice President alla Incyte Corp. Il Dr. Stein è anche nel consiglio di amministrazione di Kura Oncology, Inc. Nella sua carriera passata il Dr. Stein è stato vicepresidente di Oncologia globale presso GlaxoSmithKline (New Jersey), SVP-US Clinical Development & Medical Affairs presso Novartis Oncology, Inc. e Senior VP-US Clinical Development & Medical Affair presso Novartis Pharmaceuticals Corp. Il Dr. Stein ha ricevuto un dottorato dall'Università del Witwatersrand.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INCYTE CORPORATION
0.04% | 14/02/2024 | 97 595 ( 0.04% ) | 6 M $ | 31/03/2024 |
KURA ONCOLOGY, INC.
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Steven Stein
| Società | Posizione | Inizio |
|---|---|---|
| INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 02/03/2015 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | - |
| University of Pennsylvania | Corporate Officer/Principal | - |
Precedenti posizioni note di Steven Stein
| Società | Posizione | Fine |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | Director/Board Member | 14/02/2024 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/02/2015 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/02/2015 |
| GlaxoSmithKline (New Jersey) | Corporate Officer/Principal | 01/04/2011 |
| KURA ONCOLOGY, INC. | Director/Board Member | - |
Formazione di Steven Stein
| University of the Witwatersrand | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Steven Stein
